Sporadic schwannomas, meningiomas, and ependymomas fund in patients who do not suffer from constitutional neurofibromatosis 2 have somatic NF2 mutations at rates of 42%, 27%, and 4%, respectively[46]. This evidence concerns the gene NF2 and ependymoma.